API
< Back to all clusters
[BUSINESS] · United States, Germany, United Kingdom, Italy, France · 3 sources

started · updated

Science Corporation valued at $3.5 billion after $400 million funding round

Science Corporation, a medical technology startup founded by former Neuralink president Max Hodak, has raised $400 million in a Series D funding round. The investment, led by Khosla Ventures, brings the company’s valuation to $3.5 billion.

Participants in the round include the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech. The capital is intended to help bring the company’s flagship product, PRIMA, to the United States market via the FDA’s Humanitarian Device Exemption.

PRIMA is a wearable and implantable chip designed to help patients with age-related macular degeneration recover partial vision. While the device is already approved and in use in Germany, the company plans to expand availability to Italy, France, and the United Kingdom. Science Corporation is also trialing the technology for Stargardt’s disease and is designing human trials for a bio-hybrid sensor that could potentially treat Parkinson’s disease and other brain injuries.

Entities

Ackman Oxman Institute · FDA · Khosla Ventures · Max Hodak · Science Corporation